SCHEIBLER LUKAS Insider Trading
Get the latest insider transactions of SCHEIBLER LUKAS. SCHEIBLER LUKAS is EVP of Research & Development in ACUCELA INC. ($M??????) and EVP of Translational Medicine in ACUCELA INC. ($M??????) and CHIEF INNOVATION OFFICER in Apellis Pharmaceuticals, Inc. ($APLS) and See Remarks in Apellis Pharmaceuticals, Inc. ($APLS). Discover the current value of SCHEIBLER LUKAS shares.
Address: C/O ACUCELA INC. 1301 SECOND AVE., SUITE 4200 SEATTLE 98101WA
SCHEIBLER LUKAS is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
M?????? | KUBOTA PHARMACEUTICAL HOLDINGS CO LTD | EVP of Research & Development, EVP of Translational Medicine | 12,358 | |
APLS | Apellis Pharmaceuticals, Inc. | CHIEF INNOVATION OFFICER, See Remarks | 29,290 |
Insider Trading Transactions of SCHEIBLER LUKAS
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Feb 11 2021 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | CHIEF INNOVATION OFFI ... | Sell | 47.72 | 680 | 32,450 | 29,290 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | CHIEF INNOVATION OFFI ... | Buy | 0.00 | 7,500 | 0 | 28,095 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | CHIEF INNOVATION OFFI ... | Buy | 0.00 | 1,875 | 0 | 29,970 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | CHIEF INNOVATION OFFI ... | Option Exercise | 44.90 | 45,000 | 2,020,500 | 45,000 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | CHIEF INNOVATION OFFI ... | Option Exercise | 44.90 | 11,250 | 505,125 | 11,250 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | CHIEF INNOVATION OFFI ... | Buy | 0.00 | 7,500 | 0 | 28,095 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | CHIEF INNOVATION OFFI ... | Buy | 0.00 | 1,875 | 0 | 29,970 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | CHIEF INNOVATION OFFI ... | Option Exercise | 44.90 | 45,000 | 2,020,500 | 45,000 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | CHIEF INNOVATION OFFI ... | Option Exercise | 44.90 | 11,250 | 505,125 | 11,250 |
Dec 09 2020 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | CHIEF INNOVATION OFFI ... | Buy | 26.73 | 7,482 | 199,994 | 20,595 |
Dec 09 2020 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | CHIEF INNOVATION OFFI ... | Option Exercise | 26.73 | 7,482 | 199,994 | 137,518 |
Feb 12 2020 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | See Remarks | Buy | 0.00 | 9,375 | 0 | 12,310 |
Feb 12 2020 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | See Remarks | Option Exercise | 44.33 | 56,250 | 2,493,563 | 56,250 |
Feb 12 2019 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | See Remarks | Option Exercise | 13.85 | 85,000 | 1,177,250 | 85,000 |
May 29 2018 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | See Remarks | Buy | 20.37 | 2,935 | 59,786 | 2,935 |
Apr 17 2018 | APLS | Apellis Pharmaceuticals, ... | SCHEIBLER LUKAS | See Remarks | Option Exercise | 26.73 | 145,000 | 3,875,850 | 145,000 |
Jul 18 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Buy | 0.00 | 2,663 | 0 | 12,358 |
Jul 18 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Sell | 6.50 | 1,250 | 8,125 | 11,108 |
Jul 18 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Option Exercise | 0.00 | 2,663 | 0 | 66,587 |
Jun 20 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Buy | 0.00 | 2,664 | 0 | 10,995 |
Jun 20 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Sell | 6.95 | 1,300 | 9,035 | 9,695 |
Jun 20 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Option Exercise | 0.00 | 2,664 | 0 | 69,250 |
May 18 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Buy | 0.00 | 2,663 | 0 | 9,606 |
May 18 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Sell | 6.15 | 1,275 | 7,841 | 8,331 |
May 18 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Option Exercise | 0.00 | 2,663 | 0 | 71,914 |
Apr 17 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Buy | 0.00 | 2,664 | 0 | 8,263 |
Apr 17 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Sell | 6.48 | 1,320 | 8,554 | 6,943 |
Apr 17 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Option Exercise | 0.00 | 2,664 | 0 | 74,577 |
Mar 20 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Buy | 0.00 | 2,663 | 0 | 6,849 |
Mar 20 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Sell | 7.10 | 1,250 | 8,875 | 5,599 |
Mar 20 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Option Exercise | 0.00 | 2,663 | 0 | 77,241 |
Feb 21 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Buy | 0.00 | 2,664 | 0 | 5,636 |
Feb 21 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Sell | 8.10 | 1,450 | 11,745 | 4,186 |
Feb 21 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Option Exercise | 0.00 | 2,664 | 0 | 79,904 |
Jan 20 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Buy | 0.00 | 2,663 | 0 | 4,447 |
Jan 20 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Sell | 8.70 | 1,475 | 12,833 | 2,972 |
Jan 20 2017 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Option Exercise | 0.00 | 2,663 | 0 | 82,568 |
Dec 27 2016 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Buy | 0.00 | 2,664 | 0 | 2,664 |
Dec 27 2016 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Sell | 8.18 | 880 | 7,198 | 1,784 |
Dec 27 2016 | M?????? | KUBOTA PHARMACEUTICAL HOL ... | SCHEIBLER LUKAS | EVP of Research & Dev ... | Option Exercise | 0.00 | 2,664 | 0 | 85,231 |
Nov 21 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Dev ... | Buy | 0.00 | 2,663 | 0 | 2,663 |
Nov 21 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Dev ... | Sell | 9.35 | 2,663 | 24,891 | 0 |
Nov 21 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Dev ... | Option Exercise | 0.00 | 2,663 | 0 | 87,895 |
Nov 15 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Dev ... | Sell | 9.44 | 1,774 | 16,745 | 0 |
Oct 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Dev ... | Buy | 0.00 | 2,664 | 0 | 2,664 |
Oct 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Dev ... | Sell | 11.48 | 890 | 10,220 | 1,774 |
Oct 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Dev ... | Option Exercise | 0.00 | 2,664 | 0 | 90,558 |
Sep 20 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Dev ... | Buy | 0.00 | 2,663 | 0 | 2,663 |
Sep 20 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Dev ... | Sell | 9.53 | 2,663 | 25,382 | 0 |
Sep 20 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Dev ... | Option Exercise | 0.00 | 2,663 | 0 | 93,222 |
Aug 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Dev ... | Buy | 0.00 | 31,962 | 0 | 31,962 |
Aug 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Dev ... | Sell | 10.81 | 31,962 | 345,509 | 0 |
Aug 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Dev ... | Option Exercise | 0.00 | 31,962 | 0 | 95,885 |
Jul 14 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Dev ... | Option Exercise | 15.41 | 32,445 | 499,977 | 32,445 |
Jul 14 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Dev ... | Option Exercise | 15.41 | 87,555 | 1,349,223 | 87,555 |
Aug 19 2015 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Translational ... | Option Exercise | 0.00 | 127,847 | 0 | 127,847 |